Results 251 to 260 of about 363,404 (326)

The long-term orientation of institutional investors : an empirical investigation

, 1994
Sumit K. Majumdar
openalex   +1 more source

Global Investors, Hidden Suppliers: How Institutions Shape the Impact of Stock Market Liberalization Programs on Corporate Responsibility

Shipeng Yan, Wei Jiang, Yue Xu
openalex   +1 more source

Voting with Their Feet or Activism? Institutional Investors’ Impact on CEO Turnover

, 2011
Jean Helwege, Vincent Intintoli, J. Andrew Zhang   +2 more
openalex   +1 more source

Green investors and ESG ratings divergence. [PDF]

Sci Rep
Ge Y, Zhang R, Zhu H.
europepmc   +1 more source

Informational Herding by Institutional Investors: Evidence from Analyst Recommendations

, 2011
Jonathan Clarke, Chayawat Ornthanalai, Ya Tang   +2 more
openalex   +1 more source

Back Again to the Future: A New Era for Cerebroprotection

Annals of Neurology, EarlyView.
Cerebroprotection is a fresh framework for designing neurological therapy that targets glia and vascular cells, in addition to neurons. In the future, successful cerebroprotection will involve targeting all elements of the neurovascular unit. Preclinical trials must include functional outcomes, as well as lesion morphometry.
Patrick Lyden
wiley   +1 more source

From Lab to Industry: Advancing the Translational Potential of Extracellular Vesicles Through the ISEV Translation, Regulation and Advocacy Committee (ISEV-TRA). [PDF]

J Extracell Vesicles
Gurriaran-Rodriguez U, Bussolati B, Gimona M, Glebov K, Fujita Y, Marcilla A, Neri C, Fu QL, Das S, Pluchino S, Zarovni N, Salomon C, Witwer K, Falcon-Perez JM.   +13 more
europepmc   +1 more source

Harnessing the Neurobiology of Empathy and Compassion to Alleviate Burnout in Neurology

Annals of Neurology, EarlyView.
The neurologist cares for patients with complex chronic conditions that compromise their wellbeing. Many such disorders are poorly understood. Whereas for some, effective symptomatic treatments exist, for most we lack an understanding of the molecular and cellular bases for disease pathogenesis needed for discovering disease‐modifying treatments ...
Fadel Zeidan, Joseph D. Stern, William C. Mobley   +2 more
wiley   +1 more source

Corporate carbon emissions and market value. [PDF]

Sci Rep
Zhang J.
europepmc   +1 more source

Institutional Investors, Corporate Governance and Global Standards: An Indian Perspective

, 2010
Krishna Shorewala, Apoorvaa Paranjpe
openalex   +1 more source